4547:TYO
KISSEI藥品工業
JP¥3,695.00
0.00%
(0.00) 1 天
10月8日, GMT+9 15:30:00 · JPY
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 4547 生成关键数据洞见…
开盘价
JP¥3,710
最高价
JP¥3,720
最低价
JP¥3,670
市值
1706.56亿
平均成交量
6.96万
成交量
8.94万
股息
3.25%
季度股息
JP¥30
除息日
2026年9月29日
市盈率
10.95
52 周最高价
JP¥5,040
52 周最低价
JP¥3,500
每股收益
JP¥337
流通股数
4671.64万
员工人数
1786
开盘价
JP¥3,710
最高价
JP¥3,720
最低价
JP¥3,670
市值
1706.56亿
平均成交量
6.96万
成交量
8.94万
股息
3.25%
季度股息
JP¥30
除息日
2026年9月29日
市盈率
10.95
52 周最高价
JP¥5,040
52 周最低价
JP¥3,500
每股收益
JP¥337
流通股数
4671.64万
员工人数
1786
新闻报道
来自网络来源和新闻合作伙伴
Yahoo Finance
·
16分钟前
Nasdaq 100 Ends Lower As Report Of Weaker-Than-Expected OpenAI Revenue Drags Chipmakers — NVDA, DIS, ORCL, SBUX In Focus
The Motley Fool
·
33分钟前
History Says Every S&P 500 Bull Market That Reached Its 4th Birthday Kept Going
BigGo Finance
·
16分钟前
Oil Price Surge and AI Revenue Concerns Batter Nasdaq, Down Over 1%; Philadelphia Semiconductor Index Tumbles 3.4%
Bloomberg.com
·
1小时前
Tech Stocks to Fall as OpenAI Sinks US Chipmakers: Markets Wrap
资料
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
KISSEI藥品工業简介